Bayer announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to the Artificial Intelligence Software for Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Pattern Recognition, which Bayer is currently developing jointly with MSD (tradename of Merck & Co., Inc., Kenilworth, N.J., USA). 
Two pioneering NHS organisations have been recognised at the 2018 HTN Awards for their innovative work using InterSystems technology to help transform care for patients. The judges, who included GPs and clinical commissioning group IT leads, as well as project managers, clinical leads and IT directors from acute trusts and mental health and community providers, selected Coordinate My Care and North Tees and Hartlepool NHS Foundation Trust as winners. 
At the Congress of the Radiological Society of North America (RSNA 2018) in Chicago, USA, Siemens Healthineers is presenting AI-Pathway Companion* for the first time. It is a clinical decision support system based on artificial intelligence that supports physicians in making diagnostic and therapeutic decisions along the clinical pathway. 
Merck, a leading science and technology company, and software company Palantir Technologies, today announced their intent to form a joint venture under the brand name Syntropy. Syntropy is expected to empower scientists and research centers with a collaborative technology platform to advance cancer research, help drive scientific discovery, and improve human lives. 
Patients and clinicians will benefit from easy access to critical real-time patient information at the bedside after Australian population health services provider ACT Health signed a further contract with Patientrack's parent company Alcidion Group (ASX:ALC). 
The AOK community builds a digital health network for its insurants and thus takes on a pioneering task among German health insurances. Through the digital health network its 25 million insurants will always have a self-determined access to their health information wherever they want. 
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced publication of the latest Future Health Index (FHI) report. 'Telehealth: delivering value across institutional and geographical borders' is an independent analysis, commissioned by Philips, of the roadblocks and challenges in the deployment of telehealth services around the world.